Blog Archives
$1 million funding boost for Zero Childhood Cancer program
11/05/2018
NSW Health Minister Brad Hazzard has announced a $1 million funding boost for the Zero Childhood Cancer program. The money will support an immunotherapy trial for children with brain cancer.
Fighting fund for brain cancer aims to double survival
30/10/2017
In a landmark moment for brain cancer research, the Australian Government has established a $100 million fund to search for cures and support clinical trials.
Our science stars shine
25/10/2017
Two of our top researchers have been recognised for their outstanding contributions to science and innovation.
Resistance is futile: The MRP1 story
18/10/2017
How we got to now in our understanding of MRP1, a protein that ejects chemotherapy drugs from tumour cells and stops them stopping cancer. We're exploring future drugs that target it.
Zero Childhood Cancer personalised medicine clinical trial launched
18/09/2017
Today marked the opening of the national clinical trial for Zero Childhood Cancer, with about 400 children with high-risk cancers expected to participate over the next 3 years.
Fighting childhood cancer a Federal Budget focus
10/05/2017
Last night’s Federal Budget brought good news for Australian medical research into childhood cancer
$6.6M for much-needed neuroblastoma research
09/02/2017
Better targeted therapies for neuroblastoma are desperately needed. They’re now a step closer.
Kids’ cancer a priority
16/12/2016
Children’s cancers are a focus for three priority-driven research grants announced this week by Cancer Australia.
Grant success shows kids’ cancer research on right track
08/12/2016
Research into leukaemic stem cells, childhood brain cancer DIPG and therapies for neuroblastoma will get a boost from Australia's peak medical research funding agency, NHMRC.
We need better treatment for childhood cancer, with fewer side effects
04/11/2016
Why is targeted treatment so vital for childhood cancer and what are the barriers to getting there? An article from The Conversation by two of our researcher-clinicians.
